Bedrijfsvoering Novo Nordisk A/S

NOVO B

DK0062498333

Farmaceutische producten

Beurs gesloten - Nasdaq Copenhagen Andere beurzen 17:20:00 09-06-2026			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
269,50 ^DKK	-0,92%		-2,94%	-17,14%

09/06	Ontwikkelaars van afslankmedicijnen maken zich op voor lucratieve markt terwijl concurrentie toeneemt	RE
09/06	NOVO NORDISK : Deutsche Bank is neutraal gestemd over het aandeel	ZD

Uitvoerend comité: Novo Nordisk A/S

Bedrijfsleider

Beklede functiesVan

Maziar Mike Doustdar

56 jaar

Chief Executive Officer	07-08-2025
President	07-08-2025

Michael Novod

Investor Relations Contact

01-01-2026

John F. Kuckelman

54 jaar

General Counsel

01-01-2024

Filip Krag Knop

Chief Tech/Sci/R&D Officer

05-11-2025

Emil Kongshøj Larsen

51 jaar

Chief Operating Officer

01-08-2025

Tania Sabroe

49 jaar

Human Resources Officer

01-01-2022

Martin Lange

56 jaar

Chief Tech/Sci/R&D Officer

07-08-2025

Robin Evers

General Counsel

01-03-2024

Karsten Munk Knudsen

55 jaar

Director of Finance/CFO

15-02-2018

Thilde Hummel Bogebjerg

44 jaar

Chief Tech/Sci/R&D Officer

03-04-2025

Samenstelling van de raad van bestuur: Novo Nordisk A/S

Bestuurder

RadenVan

Lars Rebien Sørensen

71 jaar

HR Committee Chair	14-11-2025
Governance Committee Chair	14-11-2025

Cees de Jong

65 jaar

Audit Committee	14-11-2025
Compensation Committee	29-01-2024
Nominating Committee	29-01-2024
Compensation Committee Chair	14-11-2025

Stephan Engels

64 jaar

Compensation Committee	14-11-2025
HR Committee	14-11-2025
Governance Committee	14-11-2025
Audit Committee Chair	14-11-2025

Helena Ildiko Saxon

56 jaar

Audit Committee Chair
Audit Committee	26-03-2026
HR Committee	26-03-2026
Governance Committee	26-03-2026

Mette Bøjer Jensen

51 jaar

Audit Committee	01-03-2022
HR Committee	22-03-2018
Governance Committee	22-03-2018

Ramona Sequeira

60 jaar

Audit Committee	07-05-2020
HR Committee	01-07-2025
Compensation Committee	26-03-2026

Kasim Kutay

61 jaar

Compensation Committee	29-01-2024
Nominating Committee	29-01-2024

Semsi Kilic Madsen

HR Committee	26-03-2026
Governance Committee	26-03-2026

Jan van de Winkel

65 jaar

Nominating Committee	11-01-2021
Compensation Committee Chair	11-01-2021

Elisabeth Christensen

61 jaar

Compensation Committee

24-03-2022

Britt Meelby Jensen

53 jaar

Compensation Committee

14-11-2025

Desiree Asgreen

Director/Board Member

26-03-2026

Recente benoemingen: Novo Nordisk A/S

13/04	Lineage Cell Therapeutics, Inc. kondigt oprichting van Wetenschappelijke Adviesraad en benoeming van directielid aan	CI
07/04	Lytix Biopharma AS kondigt benoeming aan van Renée Christine Amundsen als Chief Operating Officer, met ingang van 7 april 2026	CI
27/03	Novo Nordisk AS kondigt bestuursbenoemingen aan	CI
26/03	Novo Nordisk A/S keurt wijzigingen in de Raad van Bestuur goed	CI
25/03	Rani Therapeutics Holdings, Inc. stelt Jesper Høiland aan als Head of Strategy	CI
02/03	Novo Nordisk A/S kondigt wijzigingen aan in werknemersvertegenwoordiging binnen de Raad van Bestuur	CI
25/02	Sleep Cycle kondigt benoemingen in het management aan	CI

Meer nieuws

Voormalige zaakvoerders en bestuurders: Novo Nordisk A/S

Insider

Beklede functies

VanTot

Stig Strøbæk

Director/Board Member

01-01-1998

24-03-2022

Anne Marie Handrup Kverneland

Director/Board Member

01-01-2000

24-03-2022

Mads Krogsgaard Thomsen

Director/Board Member	18-02-2011	09-11-2011
Chief Tech/Sci/R&D Officer	01-11-2000	01-03-2021

Jesper Brandgaard

Director of Finance/CFO	01-11-2000	15-02-2018
General Counsel	15-02-2018	01-04-2019

Göran Albert Ando

Director/Board Member	01-01-2005	20-03-2013
Chairman	20-03-2013	01-01-2018
Chief Tech/Sci/R&D Officer	08-06-2010	08-11-2011

Kåre Schultz

Chief Operating Officer	08-06-2010	30-04-2015
President	01-01-1989	30-04-2015

Hannu Ragnvald Ryöppönen

Director/Board Member	01-03-2009	19-03-2015
Independent Dir/Board Member	16-08-2011	19-03-2015

Lise Kingo

Human Resources Officer	09-11-2011	01-11-2014
Corporate Officer/Principal	08-06-2010	09-11-2011

Sten Scheibye

Chairman	01-01-2003	20-03-2013
Independent Dir/Board Member	01-01-2003	02-05-2012

Per Toft Valstorp

Corporate Officer/Principal

09-07-2009

01-01-2013

Jørgen Wedel

Director/Board Member

01-01-2000

21-03-2012

Pamela Kirby

Director/Board Member

01-01-2008

23-03-2011

Johnny Henriksen

Director/Board Member

24-03-2010

Ulrik Joakim Hjulmand-Lassen

Director/Board Member

30-03-2010

Kurt W. Briner

Director/Board Member

18-03-2009

Peter Gerhardsson

Corporate Officer/Principal

01-05-2008

Niels Jacobsen

Director/Board Member

01-01-2000

01-01-2008

Jan Ulf Sigvar J. Johansson

Director/Board Member

01-01-1998

01-03-2005

Henrik Gürtler

Director/Board Member

01-01-2005

Finn M. Ulrich

Chief Tech/Sci/R&D Officer

01-01-1996

01-01-2004

Robert Frederick Caspari

Corporate Officer/Principal

01-01-2004

Marianne Kock

Corporate Officer/Principal

01-01-1985

01-01-2002

Jack Nielsen

Corporate Officer/Principal

01-01-1990

01-01-2001

Valeta A. Gregg

Corporate Officer/Principal

01-01-1996

01-01-2001

Grethe Nørskov Rasmussen

Corporate Officer/Principal

01-01-1989

Kirsten Drejer

Corporate Officer/Principal

01-01-1991

01-01-2000

Anders Hedegaard

Sales & Marketing

01-01-1991

01-01-2000

Martin Olin

Director of Finance/CFO

01-01-1996

01-01-2000

Thomas Feldthus

Corporate Officer/Principal

01-01-1996

01-01-1999

Christian Hansen

Corporate Officer/Principal

01-01-1992

01-01-1999

Hanne Jensen

Corporate Officer/Principal

01-01-1995

01-01-1999

Jan Öhrström

Sales & Marketing

01-01-1990

01-01-1999

Anker Gunvald Lundemose

Corporate Officer/Principal

01-06-1994

01-11-1998

Peter Nordkild

Corporate Officer/Principal

01-01-1996

Harry Penner

General Counsel	01-01-1985	01-01-1988
Corporate Officer/Principal	01-01-1988	01-01-1993

Carsten Hellmann

Corporate Officer/Principal	01-01-1996	-
Sales & Marketing	01-01-1993	31-12-1995

Leif Kongerslev

Corporate Officer/Principal

01-01-1989

Johan Selmer

Corporate Officer/Principal

01-01-1983

Jørgen Ulrik Vejlsgaard

Corporate Officer/Principal

Torben Nissen

Corporate Officer/Principal

Lotte Sønderbjerg

Corporate Secretary

Mads Fischer Rasmussen

Corporate Officer/Principal

Søren Bregenholt

Chief Investment Officer	09-06-2010	-
Corporate Officer/Principal	-	09-06-2010

Ib Schneider

Corporate Officer/Principal

Kenneth William Harlow

Corporate Officer/Principal

Stephen Farr

Chief Tech/Sci/R&D Officer

Karin Hannader

Corporate Officer/Principal

Niels Jonas Heilskov Graversen

Corporate Officer/Principal

Casper Breum

Corporate Officer/Principal

Thue Walter Schwartz

Chief Tech/Sci/R&D Officer

Mads Dall

Corporate Officer/Principal

Ganesh Iyer

Corporate Officer/Principal

Pál Helmich

Corporate Officer/Principal

Tim Kehling Pedersen

Corporate Officer/Principal

Thomas Lander

Corporate Officer/Principal

Lene Gerlach

Corporate Officer/Principal

Jens Ole Pedersen

Corporate Officer/Principal

Christian Hemmingsen

Corporate Officer/Principal

Jens Morten Fogh

Chief Tech/Sci/R&D Officer

Patrick Michael Round

Corporate Officer/Principal

Claus Kühl

Corporate Officer/Principal

Jaques Arend

Corporate Officer/Principal

Martin O. Andersen

Director of Finance/CFO

Mads Buhl Axelsen

Corporate Officer/Principal

Grith Hagel

Corporate Officer/Principal

Mads Veggerby Lausten

Public Communications Contact

Sam Lindgren

Corporate Officer/Principal

Steen Klysner

Corporate Officer/Principal

Joe A. Young

Sales & Marketing

Jens Frederik Lage Hansen

Sales & Marketing

Mike Rulis

Public Communications Contact

Hans Schambye

Corporate Officer/Principal

Esper Boel

Corporate Officer/Principal

Niels Hvid

Corporate Officer/Principal

Bolette Wildt

General Counsel	-	14-07-2011
Corporate Officer/Principal	14-07-2011	-

Mogens Vang Rasmussen

Corporate Officer/Principal

Anders Pedersen

Corporate Officer/Principal

Michael J. Dwyer

Sales & Marketing

Jakob Dynnes Hansen

Corporate Officer/Principal

Peter W. Ravn

Corporate Officer/Principal

Jeppe Vesti Christensen

Corporate Officer/Principal

Per Bo Pedersen Fischer

Corporate Officer/Principal

Mads Øvlisen

Chairman

Stephan Christgau

Chief Tech/Sci/R&D Officer

Christian Meyer

Corporate Officer/Principal

Henrik Dalbøge

Corporate Officer/Principal

Ole Thastrup

Corporate Officer/Principal

Jürgen Langhärig

Corporate Officer/Principal

Tina Kragh-Jakobsen

Corporate Officer/Principal

Leeftijdsdistributie van bedrijfsleiders

Ratio vrouwen/mannen

Man	21
Vrouw	11

Waarvan leden van het uitvoerend comité

Man	8
Vrouw	2

Waarvan bestuurders

Man	6
Vrouw	6

Herzieningen

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Nee

Controverses sur les droits de l'Homme

Nee

Controverses Subventions fiscales

Nee

Conforme à la finance Islamique

Novo Nordisk A/S is gespecialiseerd in het ontwerpen, produceren en op de markt brengen van farmaceutische producten. De netto-omzet is als volgt verdeeld over de verschillende productgroepen: - producten voor de behandeling van diabetes en obesitas (93,7%); - producten voor de behandeling van zeldzame ziekten (6,3%): bedoeld voor de behandeling van hemofilie, bloedaandoeningen, hormonale stoornissen, enz. De netto-omzet is geografisch als volgt verdeeld: Europa en Canada (21,4%), de Verenigde Staten (56%), Latijns-Amerika/Midden-Oosten/Afrika (9,9%), China/Hongkong/Taiwan (6%), Azië/Pacific (6,7%).

Werknemers

67.900

Sector

Farmaceutische producten

Agenda

Publicatie van de resultaten - Q2 2026

Meer informatie over het bedrijf